Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.

Se Yoon ParkJoo Hee JungHyunwook KwonSung ShinYoung Hoon KimYong-Phil ChongSang-Oh LeeSang-Ho ChoiYang Soo KimJun Hee WooSung Han KimDuck Jong Han

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2020)

Post-prophylaxis PCP occurred in <2% of KTRs, and about two-thirds of these experienced rejection or CMV infection. These data suggest that at least 6 to 9-month additional chemoprophylaxis may be needed to prevent PCP in KTRs with transplant rejection or CMV infection.

Keyphrases

risk factors
big data
intensive care unit
antibiotic resistance genes
artificial intelligence
wastewater treatment
respiratory failure
extracorporeal membrane oxygenation
anaerobic digestion